News

SNIPR BIOME Initiates First-in-Human Clinical Trial with SNIPR001

SNIPR BIOME Initiates First-in-Human Clinical Trial with SNIPR001

BENZIGA | SNIPR BIOME ApS, a leading CRISPR and microbiome gene therapy biotechnology company, announced dosing of the first human subjects in its phase 1 clinical trial with SNIPR001, an orally administered CRISPR-based therapeutic.

Full Story